Search
Migraine Paid Clinical Trials in Illinois
A listing of 17 Migraine clinical trials in Illinois actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
13 - 17 of 17
The state of Illinois currently has 17 active clinical trials seeking participants for Migraine research studies. These trials are conducted in various cities, including Chicago, Peoria, Springfield and Urbana.
Featured Trial
Child/Teen Migraine Study
Recruiting
Become part of a clinical trial today and play a role in driving medical research forward, aiding in the discovery of groundbreaking therapies. Get rewarded for your time with monetary compensation and enjoy access to medical treatment at no charge.
Featured Trial
Major Depressive Disorder Clinical Study
Recruiting
Is depression weighing you down? Local major depressive disorder clinical studies are now enrolling participants in the area. Participating in research studies helps contribute to the advancement of future medicine and treatment options. There is no obligation to take part and health insurance is not required.
Conditions:
Major Depressive Disorder
Major Depression
Major Depressive Episode
Major Depressive Disorder (MDD)
Major Depressive Disorders
Featured Trial
Migraine Clinical Trial
Recruiting
Migraine clinical trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Migraine
Migraine Disorders
Migraine Headache
Chronic Migraine
Headache
Featured Trial
Hyperacusis Activities Treatment-Online Study
Recruiting
Are you experiencing hyperacusis? If so, we are recruiting adults with hyperacusis to complete a clinical trial supported by the National Institutes of Health. The study involves participating in a remote counseling program and sound therapy trial for hyperacusis, Hyperacusis Activities Treatment-Online.
Conditions:
Hyperacusis
Tinnitus
Hearing Loss
A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Patients 6 to 17 Years of Age
Recruiting
The primary objective of the study is to evaluate the effectiveness of fremanezumab as compared to placebo for the preventive treatment of chronic migraine (CM).
Secondary objectives are to further demonstrate the efficacy of Fremanezumab as compared to placebo for the preventive treatment of CM, to evaluate the safety and tolerability of Fremanezumab in the preventive treatment of CM and to evaluate the immunogenicity of Fremanezumab and the impact of antidrug antibodies (ADAs) on clinical out... Read More
Gender:
All
Ages:
Between 6 years and 17 years
Trial Updated:
02/28/2024
Locations: Teva Investigational Site 14263, Hoffman Estates, Illinois +1 locations
Conditions: Migraine
A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents
Recruiting
The primary objective of the study is to evaluate the long-term safety and tolerability of subcutaneous fremanezumab in the preventive treatment of migraine in pediatric participants 6 to 17 years of age (inclusive at enrollment in the pivotal study).
Secondary objectives are to evaluate the efficacy of subcutaneous fremanezumab in pediatric participants with migraine and to evaluate the immunogenicity of fremanezumab and the impact of ADAs on clinical outcomes in pediatric participants exposed... Read More
Gender:
All
Ages:
Between 6 years and 17 years
Trial Updated:
02/22/2024
Locations: Teva Investigational Site 14263, Hoffman Estates, Illinois
Conditions: Migraine
Ubrogepant treatmeNt in mIgraine Patients Utilizing mOnoclonal aNtibodies
Recruiting
This is a prospective open-label randomized study assessing similar endpoints included in the pivotal trial for ubrogepant, which are pain freedom and freedom from the most bothersome symptom at two hours. Patients between 18-75 years old with a one-year history of migraine who experience ≥3 migraine days/month will be screened. This study will include migraine patients treated with or without injectable CGRPmAbs. As was the case in the clinical trials, this will be a single-attack study. Patien... Read More
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
02/08/2024
Locations: Chicago Headache Center & Research Institute, Chicago, Illinois +1 locations
Conditions: Headache, Migraine
COACT Study: CGRPmAbs + OnabotulinumtoxinA Assessment of Chronic Migraine Treatments Study
Recruiting
Chronic migraine patients treated with OnabotulinumtoxinA may experience breakthrough headaches, especially toward the end of their 12-week therapy. The addition of a CGRPmAb could help in decreasing or eliminating these episodes, but this combination is considered "experimental" by many payers, which often leads to a denial of coverage. Currently, there is no reference in the literature or data to support the treatment of chronic migraine with OnabotulinumtoxinA and CGRPmAbs (Aimovig, Ajovy, Em... Read More
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
02/08/2024
Locations: Chicago Headache Center & Research Institute, Chicago, Illinois
Conditions: Chronic Migraine, Headache
The Effect of Daylight Saving Time Transitions on Sleep and Migraine Headaches.
Recruiting
A prospective study that investigates the impact of circadian rhythm disturbances due to daylight saving time transitions on migraine patients.
The Primary aim is to investigate the impact of springtime DST (March 12 2023 at 2 AM on Sunday) on sleep metrics in patients with migraine headaches. Secondary aim is to examine the association between incidence of migraine headaches and sleep metrics with time transitions.
Participants will be provided with a Withings non-wearable/contactless sleep t... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
02/15/2023
Locations: OSF HealthCare Saint Francis Medical Center, Peoria, Illinois
Conditions: Episodic Migraine